Evidence map›Paper›PMID 10500218›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA.

G L Gallia, N Darbinian, A Tretiakova, S A Ansari, J Rappaport, J Brady, M J Wortman, E M Johnson, K Khalili

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

G L GalliaCenter for NeuroVirology and NeuroOncology, MCP Hahnemann University, Philadelphia, PA 19102, USA.
N Darbinian
A Tretiakova
S A Ansari
J Rappaport
J Brady
M J Wortman
E M Johnson
K Khalili
National Cancer Institute · USNational Institutes of Health · USIcahn School of Medicine at Mount Sinai · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction between two regulatory proteins plays a crucial role in the control of several biological events, including gene transcription. In this report, we demonstrate that the interaction between the cellular sequence-specific single-stranded DNA binding protein Puralpha and the HIV type 1 (HIV-1) Tat protein is mediated by specific ribonucleic acids. The region of Tat that is important for its interaction with Puralpha includes the region demonstrated to bind Tat's viral RNA target, TAR. A 10-nucleotide GC-rich consensus sequence identified in RNAs associated with Puralpha derived from human U-87MG cells plays an important role in the Puralpha:Tat interaction as examined by an in vitro reconstitution assay. Furthermore, expression of the Puralpha-associated RNA in these cells enhances transcriptional activation of the HIV-1 promoter by Tat and Puralpha.

Indexed as

Cyclic AMP Response Element-Binding ProteinDNA-Binding ProteinsGene Products, tatHIV-1HumansPromoter Regions, GeneticRNA, Viraltat Gene Products, Human Immunodeficiency VirusTranscriptional ActivationTranscription FactorsCyclic AMP Response Element-Binding ProteinDNA-Binding ProteinsGene Products, tatPURA protein, humanRNA, Viraltat Gene Products, Human Immunodeficiency VirusTranscription Factors

Identifiers

PMID10500218
PMCPMC18075
OpenAlexW1972800880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.